Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Klrg2 | Mouse | (+)-schisandrin B | multiple interactions | ISO | Klrg2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KLRG2 mRNA] | CTD | PMID:31150632 | Klrg2 | Mouse | 17beta-estradiol | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of KLRG2 mRNA | CTD | PMID:19167446 | Klrg2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of KLRG2 mRNA | CTD | PMID:19770486 | Klrg2 | Mouse | 3,4-dichloroaniline | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | 3 and 4-dichloroaniline results in decreased expression of KLRG2 mRNA | CTD | PMID:24172598 | Klrg2 | Mouse | actinomycin D | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of KLRG2 mRNA | CTD | PMID:38460933 | Klrg2 | Mouse | aflatoxin M1 | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of KLRG2 mRNA | CTD | PMID:30928695 | Klrg2 | Mouse | alpha-Zearalanol | multiple interactions | ISO | Klrg2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of KLRG2 mRNA | CTD | PMID:35163327 | Klrg2 | Mouse | antirheumatic drug | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of KLRG2 mRNA | CTD | PMID:24449571 | Klrg2 | Mouse | benzo[a]pyrene | affects methylation | ISO | KLRG2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of KLRG2 promoter | CTD | PMID:27901495 | Klrg2 | Mouse | benzo[a]pyrene | increases methylation | ISO | KLRG2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of KLRG2 exon | CTD | PMID:27901495 | Klrg2 | Mouse | butanal | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of KLRG2 mRNA | CTD | PMID:26079696 | Klrg2 | Mouse | camptothecin | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of KLRG2 mRNA | CTD | PMID:38460933 | Klrg2 | Mouse | cantharidin | increases expression | EXP | | 6480464 | Cantharidin results in increased expression of KLRG2 mRNA | CTD | PMID:36907384 | Klrg2 | Mouse | cisplatin | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of KLRG2 mRNA | CTD | PMID:27392435 | Klrg2 | Mouse | cisplatin | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of KLRG2 mRNA | CTD | PMID:27392435 | Klrg2 | Mouse | coumestrol | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of KLRG2 mRNA | CTD | PMID:19167446 | Klrg2 | Mouse | diuron | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Diuron metabolite results in decreased expression of KLRG2 mRNA | CTD | PMID:24172598 | Klrg2 | Mouse | dorsomorphin | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Klrg2 | Mouse | endosulfan | increases expression | ISO | Klrg2 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of KLRG2 mRNA | CTD | PMID:29391264 | Klrg2 | Mouse | entinostat | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | entinostat results in increased expression of KLRG2 mRNA | CTD | PMID:26272509 | Klrg2 | Mouse | entinostat | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLRG2 mRNA | CTD | PMID:27188386 | Klrg2 | Mouse | formaldehyde | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of KLRG2 mRNA | CTD | PMID:27664576 | Klrg2 | Mouse | gentamycin | decreases expression | ISO | Klrg2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of KLRG2 mRNA | CTD | PMID:33387578 | Klrg2 | Mouse | hydroquinone | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of KLRG2 mRNA | CTD | PMID:31256213 | Klrg2 | Mouse | nickel atom | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of KLRG2 mRNA | CTD | PMID:24768652 and PMID:25583101 | Klrg2 | Mouse | Nutlin-3 | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of KLRG2 mRNA | CTD | PMID:38460933 | Klrg2 | Mouse | panobinostat | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | panobinostat results in increased expression of KLRG2 mRNA | CTD | PMID:26272509 | Klrg2 | Mouse | panobinostat | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLRG2 mRNA | CTD | PMID:27188386 | Klrg2 | Mouse | paracetamol | decreases expression | ISO | Klrg2 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of KLRG2 mRNA | CTD | PMID:30723492 and PMID:33387578 | Klrg2 | Mouse | pentanal | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | pentanal results in increased expression of KLRG2 mRNA | CTD | PMID:26079696 | Klrg2 | Mouse | perfluorooctanoic acid | multiple interactions | ISO | Klrg2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of KLRG2 mRNA | CTD | PMID:35163327 | Klrg2 | Mouse | propanal | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of KLRG2 mRNA | CTD | PMID:26079696 | Klrg2 | Mouse | resveratrol | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of KLRG2 mRNA | CTD | PMID:19167446 | Klrg2 | Mouse | SB 431542 | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Klrg2 | Mouse | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of KLRG2 mRNA | CTD | PMID:37682722 | Klrg2 | Mouse | sodium dodecyl sulfate | decreases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of KLRG2 mRNA | CTD | PMID:31734321 | Klrg2 | Mouse | tetrachloromethane | multiple interactions | ISO | Klrg2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KLRG2 mRNA] | CTD | PMID:31150632 | Klrg2 | Mouse | tetrachloromethane | increases expression | ISO | Klrg2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of KLRG2 mRNA | CTD | PMID:31150632 | Klrg2 | Mouse | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of KLRG2 mRNA | CTD | PMID:29264374 | Klrg2 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of KLRG2 gene | CTD | PMID:35295148 | Klrg2 | Mouse | trichostatin A | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of KLRG2 mRNA | CTD | PMID:24935251 | Klrg2 | Mouse | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of KLRG2 mRNA | CTD | PMID:21427059 | Klrg2 | Mouse | valproic acid | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of KLRG2 mRNA | CTD | PMID:23179753 more ... | Klrg2 | Mouse | valproic acid | multiple interactions | ISO | KLRG2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLRG2 mRNA | CTD | PMID:27188386 | Klrg2 | Mouse | zoledronic acid | increases expression | ISO | KLRG2 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of KLRG2 mRNA | CTD | PMID:24714768 | |